Skip to main content

Table 3 The surface phenotype of DCs

From: A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma

Patient ID

% Expression

 

CD14

CD1a

HLA-ABC

HLA-DR

CCR7

CD40

CD80

CD83

CD86

1802

7.8

51.6

98.7

99.7

10.6

99.9

96.4

60.1

96.3

1803

1.4

79.6

99.2

99.9

38.7

99.4

99.1

94.1

99.5

1806

1.5

36.3

99.8

99.8

49.1

99.9

98.5

90.8

99

1808

5.2

53.3

98.8

99.5

43.1

99.4

96.7

75.6

98.7

1812

0.6

83

99.9

99.7

10.3

99.8

99.2

87.4

97.9

1814

0.6

66.5

99.4

99.4

58.3

99.6

98.7

91.5

99.2

1817

1.4

34.7

99.7

98.3

50.3

99.8

96.7

61.8

98

1823

0.8

50.4

99.7

99.6

30.5

99.7

99.3

95.4

99.3